St. Jude Medical Completes Acquisition Of Privately-held CardioMEMS

(RTTNews) - St. Jude Medical, Inc. (STJ), a global medical device company, said it has completed its acquisition of privately-held CardioMEMS, Inc., developer of the CardioMEMS HF System. The acquisition was completed on May 30.

The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device proven to significantly reduce hospital admissions when used by physicians to manage heart failure. St. Jude Medical will now begin its strategic launch of the CardioMEMS HF System in the U.S.

BofA Merrill Lynch acted as financial advisor and Gibson, Dunn & Crutcher LLP as legal counsel to St. Jude Medical.

J.P. Morgan Securities LLC was the financial advisor to CardioMEMS and Cooley LLP was its legal counsel.